Tumor- and host-derived heparanase-2 (Hpa2) attenuates tumorigenicity: role of Hpa2 in macrophage polarization and BRD7 nuclear localization
2024

Heparanase-2's Role in Cervical Cancer

Sample size: 180 publication 10 minutes Evidence: high

Author Information

Author(s): Soboh Soaad, Vorontsova Avital, Farhoud Malik, Barash Uri, Naroditsky Inna, Gross-Cohen Miriam, Weissmann Marina, Yasuhiko Nishioka, Woolf Adrian S., Roberts Neil A., Shaked Yuval, Ilan Neta, Vlodavsky Israel

Primary Institution: Technion Integrated Cancer Center, Rappaport Faculty of Medicine, Technion, Haifa, Israel

Hypothesis

Heparanase-2 (Hpa2) functions as a tumor suppressor in cervical carcinoma.

Conclusion

High levels of Hpa2 are associated with prolonged survival in cervical cancer patients and reduced tumor growth.

Supporting Evidence

  • High levels of Hpa2 correlate with prolonged survival of cervical carcinoma patients.
  • Overexpression of Hpa2 in cervical carcinoma cells resulted in smaller tumor xenografts.
  • Hpa2 plays a critical role in macrophage polarization.
  • Macrophages lacking Hpa2 shifted towards a pro-tumorigenic M2 phenotype.
  • BRD7 interacts with Hpa2 and is involved in its nuclear localization.
  • High levels of Hpa2 staining correlate with lower tumor grades.
  • Conditional Hpa2-KO mice showed increased tumor growth when co-implanted with Hpa2-KO macrophages.

Takeaway

Hpa2 helps keep cancer cells from growing too much, and having more of it can help patients live longer.

Methodology

The study used a tissue microarray of cervical carcinoma biopsies and conditional Hpa2-KO mice to assess the role of Hpa2.

Statistical Information

P-Value

p=0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/s41419-024-07262-9

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication